Who owns Sitryx Therapeutics?

Sitryx Therapeutics is currently owned by Sofinnova Partners, through Sofinnova Capital X, since 2021.

When did Sofinnova Partners acquire Sitryx Therapeutics?

Sofinnova Partners acquired Sitryx Therapeutics in 2021 (active for 5 years).

Home/Companies/Biotech/Sitryx Therapeutics

Sitryx Therapeutics

Biotech·

UK·Active·5yr hold

Sitryx Therapeutics is a healthcare / biotech company, headquartered in United Kingdom.

Entry

2021

Hold

5yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQUnited Kingdom

SectorHealthcare / Biotech

UK company developing metabolic immunology therapies that modulate cell metabolism for immuno-oncology and inflammatory diseases.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Capital X

Other portfolio companies in the same fund.

DISCO Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings